insights_auto
Why is GH down 5.06%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
$144.03
arrow_downward
-5.06%(-7.67) 1D
$147.54
arrow_upward
+2.44% (+3.51)bedtimeAfter hours
Closed: Nov 16, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
$149.56
High
$149.60
Low
$143.62
Mkt. cap
19.49B
Avg. vol.
2.11M
Volume
292.00
52-wk high
$191.01
52-wk low
$74.55
EPS
-$3.68
Beta
1.67
Shares outstanding
135.29M
No. of employees
2K
Open
$149.56
High
$149.60
Low
$143.62
Mkt. cap
19.49B
Avg. vol.
2.11M
Volume
292.00
52-wk high
$191.01
52-wk low
$74.55
EPS
-$3.68
Beta
1.67
Shares outstanding
135.29M
No. of employees
2K
News stories
From web sources and news partners
Investing.com UK
·
11 hours ago
Form 144 Guardant Health For: 16 November By Investing.com
TradingView
·
1 day ago
Reflecting on testing & diagnostics services stocks’ Q3 earnings: Guardant Health
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2.5K
Founded2012
HeadquartersPalo Alto, California, United States
SectorHealth Care
IndustryHealth care provider
Websiteguardanthealth.com